Key GI Journal Articles - Gastric

Capecitabine and Oxaliplatin for Advanced Esophagogastric Cancer
D Cunningham, N Starling, S Rao, T Iveson, M Nicolson, F Coxon, G Middleton, F Daniel, J Oates, & AR Norman
NEJM. Jan 3 2008; 358(1):36-46
Journal | Pubmed

Clinical Benefit With Docetaxel Plus Fluorouracil and Cisplatin Compared With Cisplatin and Fluorouracil in a Phase III Trial of Advanced Gastric or Gastroesophageal Cancer Adenocarcinoma: The V-325 Study Group
JA Ajani, VM Moiseyenko, S Tjulandin, A Majlis, M Constenla, C Boni, A Rodrigues, M Fodor, Y Chao, E Voznyi, C Marabotti, & E Van Cutsem
JCO. Aug 1 2007; 25(22):3205-9
Journal | Pubmed

Docetaxel, Cisplatin, and Fluorouracil; Docetaxel and Cisplatin; and Epirubicin, Cisplatin, and Fluorouracil As Systemic Treatment for Advanced Gastric Carcinoma: A Randomized Phase II Trial of the Swiss Group for Clinical Cancer Research
AD Roth, N Fazio, R Stupp, S Falk, J Bernhard, P Saletti, D Köberle, MM Borner, K Rufibach, R Maibach, M Wernli, M Leslie, R Glynne-Jones, L Widmer, M Seymour, & F de Braud
JCO. Aug 1 2007; 25(22):3217-23
Journal | Pubmed

Perioperative Chemotherapy versus Surgery Alone for Resectable Gastroesophageal Cancer
D Cunningham, WH Allum, SP Stenning, JN Thompson, CJH Van de Velde, M Nicolson, JH Scarffe, FJ Lofts, SJ Falk, TJ Iveson, DB Smith, RE Langley, M Verma, S Weeden, & YJ Chua; the MAGIC Trial Participants
NEJM. Jul 6 2006; 355(1):11-20
Journal | Pubmed

Chemotherapy in Advanced Gastric Cancer: A Systematic Review and Meta-Analysis Based on Aggregate Data *New*
AD Wagner, W Grothe, J Haerting, G Kleber, A Grothey, & WE Fleig
JCO. Jun 20 2006; 24(18):2903-9
Journal | Pubmed

Randomized Multicenter Phase II Trial of a Biweekly Regimen of Fluorouracil and Leucovorin (LV5FU2), LV5FU2 Plus Cisplatin, or LV5FU2 Plus Irinotecan in Patients With Previously Untreated Metastatic Gastric Cancer: A Fédération Francophone de Cancérologie Digestive Group Study—FFCD 9803
O Bouché, JL Raoul, F Bonnetain, M Giovannini, PL Etienne, G Lledo, D Arsène, JF Paitel, V Guérin-Meyer, E Mitry, B Buecher, MC Kaminsky, JF Seitz, P Rougier, L Bedenne, & C Milan
JCO. Nov 1 2004; 22(21):4319-28
Journal | Pubmed

Chemoradiotherapy after Surgery Compared with Surgery Alone for Adenocarcinoma of the Stomach or Gastroesophageal Junction
JS Macdonald, SR Smalley, J Benedetti, SA Hundahl, NC Estes, GN Stemmermann, DG Haller, JA Ajani, LL Gunderson, JM  Jessup, & JA Martenson
NEJM. Sep 6 2001; 345(10):725-30
Journal | Pubmed

Final Results of a Randomized Phase III Trial of Sequential High-Dose Methotrexate, Fluorouracil, and Doxorubicin Versus Etoposide, Leucovorin, and Fluorouracil Versus Infusional Fluorouracil and Cisplatin in Advanced Gastric Cancer: A Trial of the European Organization for Research and Treatment of Cancer Gastrointestinal Tract Cancer Cooperative Group
U Vanhoefer, P Rougier, H Wilke, MP Ducreux, AJ Lacave, E Van Cutsem, M Planker, J Guimaraes Dos Santos, P Piedbois, B Paillot, H Bodenstein, HJ Schmoll, H Bleiberg, B Nordlinger, ML Couvreur, B Baron, & JA Wils
JCO. Jul 2000; 18(14):2648-57
Journal | Pubmed

Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer
A Webb, D Cunningham, JH Scarffe, P Harper, A Norman, JK Joffe, M Hughes, J Mansi, M Findlay, A Hill, J Oates, M Nicolson, T Hickish, M O'Brien, T Iveson, M Watson, C Underhill, A Wardley & M Meehan
JCO. Jan 1997; 15(1):261-7
Journal | Pubmed

Back to Top